Globus Medical, Inc. Class A Common Stock (GMED)
Cost of Revenue
$989.14M
TTM · Period ending: · USD
GMED Cost of Revenue
Latest reported$989.14Mperiod ending
Latest reported$989.14Mperiod ending
GMED TTM Cost of Revenue ($68.80M → $989.14M)
TTM cost of revenue
High-resolution chart · PNG
GMED cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 989,143,000 | |
| 996,469,000 | |
| 957,800,000 | |
| 989,975,000 | |
| 978,114,000 | |
| 989,389,000 | |
| 1,035,479,000 | |
| 1,037,528,000 | |
| 902,403,000 | |
| 718,836,000 | |
| 548,174,000 | |
| 353,279,000 | |
| 283,386,000 | |
| 275,383,000 | |
| 263,725,000 | |
| 254,930,000 | |
| 247,987,000 | |
| 243,363,000 | |
| 239,223,000 | |
| 238,286,000 | |
| 236,829,000 | |
| 223,626,000 | |
| 217,463,000 | |
| 205,365,000 | |
| 193,655,000 | |
| 187,002,000 | |
| 179,976,000 | |
| 177,169,000 | |
| 169,631,000 | |
| 163,278,000 | |
| 159,410,000 | |
| 154,312,000 | |
| 153,261,000 | |
| 152,823,000 | |
| 150,453,000 | |
| 148,599,000 | |
| 143,254,000 | |
| 138,786,000 | |
| 134,705,000 | |
| 130,768,000 | |
| 132,242,000 | |
| 132,090,000 | |
| 132,678,000 | |
| 128,889,000 | |
| 123,648,000 | |
| 117,652,000 | |
| 110,857,000 | |
| 106,355,000 | |
| 103,984,000 | |
| 102,162,000 | |
| 100,343,000 | |
| 93,126,000 | |
| 86,683,000 | |
| 80,301,000 | |
| 75,199,000 | |
| 75,129,000 | |
| 73,398,000 | |
| 72,288,000 | |
| 68,796,000 |